PubMed · 1991 · 147 citations · 20 references
Codon 61Thyroid TumorsSomatic VariantOncogenic AgentMedicineGeneticsThyroid DiseasePathologyThyroid HormoneRas Codon 61OncologyDietary IodineCancer ResearchIodide-deficient AreaTumor Biology
Using polymerase chain reaction and sequence-specific oligonucleotide hybridization, the frequency of three ras oncogene mutations (N-ras, Ha-ras, and K-ras) in thyroid tumors (25 adenomas, 16 follicular carcinomas, and 22 papillary carcinomas) was investigated in both iodide-deficient and iodide-sufficient areas. The ras oncogene mutation rate was significantly higher in the iodide-deficient area, being 85 versus 17% in the adenomas, and 50 versus 10% in the follicular carcinomas. No mutations were found in papillary carcinomas. The most common mutation site was Ha-ras codon 61 with Gln----Arg substitution. Two ras mutations at codon 61 (Gln----Lys in N-ras and Gln----Arg in Ha-ras) were found in a microfollicular adenoma specimen from Eastern Hungary. We conclude that dietary iodine may modulate ras oncogene mutations, and that in the iodide-deficient area, ras oncogene activation may play a more important role in the initiation and/or maintenance of follicular tumors. Additional factors are, however, necessary to initiate carcinogenesis.
20
ras oncogenes in human cancer: a review.
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
Concepción Almoguera, Darryl Shibata, Kathleen Forrester et al. · Cell · 1988 · 2.1K citations
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas
Vincent T.H.B.M. Smit, A J Boot, Alida M.M. Smits et al. · Nucleic Acids Research · 1988 · 626 citations · Full text